Jin Medical International Ltd.
ZJYL | NASDAQ
$2.29
-$0.06 (-2.55%)
Nov 2, 2026, 12:02 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Sep 30, 2025 | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 | FY 2020 Sep 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 20.69M | 23.5M | 19.82M | 19.19M | 20.76M | 16.19M |
Cost of Revenue | 14.64M | 14M | 13.04M | 12.99M | 14.4M | 10.7M |
Gross Profit | 6.04M | 9.5M | 6.78M | 6.2M | 6.36M | 5.5M |
Operating Income | 608.18K | 3.64M | 2.87M | 2.13M | 2.63M | 2.35M |
Interest Income | 789.07K | 466.52K | 182.68K | 181.61K | n/a | n/a |
Pretax Income | 1.6M | 4.18M | 3.22M | 2.74M | 2.88M | 2.35M |
Net Income | 1.19M | 3.68M | 2.88M | 2.71M | 2.63M | 2.21M |
Selling & General & Admin | 3.88M | 4.37M | 2.37M | 2.18M | 2.16M | 1.88M |
Research & Development | 1.56M | 1.5M | 1.54M | 1.89M | 1.57M | 1.26M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 5.44M | 5.86M | 3.92M | 4.07M | 3.73M | 3.14M |
Interest Expense | n/a | n/a | n/a | n/a | 9.49K | 112.4K |
Selling & Marketing Expenses | 1.35M | 1.1M | 453.31K | 402.01K | 489K | 385.09K |
Cost & Expenses | 20.08M | 19.86M | 16.95M | 17.06M | 18.13M | 13.84M |
Income Tax Expense | 214.57K | 763.88K | 343.71K | 36.11K | 248.64K | 147.15K |
Shares Outstanding (Basic) | 7.83M | 7.82M | 7.26M | 6.75M | 13.38M | 20M |
Shares Outstanding (Diluted) | 7.83M | 7.82M | 7.26M | 6.75M | 13.38M | 20M |
EPS (Basic) | 0.15 | 0.47 | 0.40 | 0.40 | 0.20 | 0.11 |
EPS (Diluted) | 0.15 | 0.47 | 0.40 | 0.40 | 0.20 | 0.11 |
EBITDA | 932.87K | 3.98M | 3.09M | 3.1M | 3.23M | 2.79M |
EBIT | 608.18K | 3.64M | 2.87M | 2.74M | 2.89M | 2.47M |
Depreciation & Amortization | 324.68K | 346.13K | 225.9K | 357.27K | 341.25K | 324.93K |
Add to Watchlist
Select watchlists to add or remove ZJYL